The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of second degree cystocele.
It was reported that after implant, the patient experienced uterine prolapse, vaginal and vaginal vault prolapse, stress urinary incontinence, with urethral hypermobility, right ureterolysis, abdominal enterocele, rectocele, cervical prolapse, pain, urinary problems, bowel problems, fistulae, recurrence, dyspareunia, recurrent cystocele, urinary tract infections, urinary retention, self-catheterization, nocturia, incomplete stool emptying, straining for urination, dribbling, hematuria, numbness in the left thigh and left vulva, perineal numbness, constipation, vaginal pain, difficulty initiating stream, bladder spasms, discomfort walking and standing due to fallen bladder, and vaginitis.
Post-operative patient treatment included surgical and nonsurgical interventions, including hysterectomy.
|